Patent details

Basic Information

Publication number:

EP2687608

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP131815151

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Methods for the identification, assessment, and treatment of patients with cancer therapy

French Title of Invention:

Procédés pour l'identification, l'évaluation et le traitement de patients suivant une cancérothérapie

German Title of Invention:

Verfahren zur Identifikation, Beurteilung und Behandlung von Patienten mit Krebstherapie

SPC Number:

Dates

Filing date:

08/06/2006

Grant date:

08/02/2017

EP Publication Date:

22/01/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/02/2017

EP B1 Publication Date:

08/02/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/06/2017

Expiration date:

08/06/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/02/2017

 

 

Name:

MILLENNIUM PHARMACEUTICALS, INC.

Address:

40 Landsdowne Street, Cambridge, MA 02139, United States (US)

Inventor

1

Name:

Damokosh, Andrew

Address:

United States (US)

2

Name:

Bryant, Barbara

Address:

United States (US)

3

Name:

Mulligan, George

Address:

United States (US)

Priority

Priority Number:

688634 P

Priority Date:

08/06/2005

Priority Country:

United States (US)

Classification

IPC classification:

C12Q 1/68;

Publication

European Patent Bulletin

Issue number:

201706

Publication date:

08/02/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/10/2017	Outgoing Correspondence	1